56 related articles for article (PubMed ID: 32311294)
1. Tumor Mutation Burden Computation in Two Pan-Cancer Precision Medicine Next-Generation Sequencing Panels.
Shu Y; Wu X; Shen J; Luo D; Li X; Wang H; Tang YT
J Comput Biol; 2020 Oct; 27(10):1553-1560. PubMed ID: 32311294
[TBL] [Abstract][Full Text] [Related]
2. Comparison of commonly used solid tumor targeted gene sequencing panels for estimating tumor mutation burden shows analytical and prognostic concordance within the cancer genome atlas cohort.
Bevins N; Sun S; Gaieb Z; Thorson JA; Murray SS
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217764
[TBL] [Abstract][Full Text] [Related]
3. Tumor Mutation Burden as a Cornerstone in Precision Oncology Landscapes: Effect of Panel Size and Uncertainty in Cutoffs.
Budak B; Arga KY
OMICS; 2024 Apr; 28(4):193-203. PubMed ID: 38657109
[TBL] [Abstract][Full Text] [Related]
4. Assessments of tumor mutational burden estimation by targeted panel sequencing: A comprehensive simulation analysis.
Li D; Wang D; Johann DJ; Hong H; Xu J
Exp Biol Med (Maywood); 2023 Nov; 248(21):1918-1926. PubMed ID: 38062992
[TBL] [Abstract][Full Text] [Related]
5. Tumor mutational burden quantification from targeted gene panels: major advancements and challenges.
Fancello L; Gandini S; Pelicci PG; Mazzarella L
J Immunother Cancer; 2019 Jul; 7(1):183. PubMed ID: 31307554
[TBL] [Abstract][Full Text] [Related]
6. Application of Next Generation Sequencing in Laboratory Medicine.
Zhong Y; Xu F; Wu J; Schubert J; Li MM
Ann Lab Med; 2021 Jan; 41(1):25-43. PubMed ID: 32829577
[TBL] [Abstract][Full Text] [Related]
7. Knowledge base toward understanding actionable alterations and realizing precision oncology.
Takeuchi S; Okuda S
Int J Clin Oncol; 2019 Feb; 24(2):123-130. PubMed ID: 30542800
[TBL] [Abstract][Full Text] [Related]
8. Systematic Functional Annotation of Somatic Mutations in Cancer.
Ng PK; Li J; Jeong KJ; Shao S; Chen H; Tsang YH; Sengupta S; Wang Z; Bhavana VH; Tran R; Soewito S; Minussi DC; Moreno D; Kong K; Dogruluk T; Lu H; Gao J; Tokheim C; Zhou DC; Johnson AM; Zeng J; Ip CKM; Ju Z; Wester M; Yu S; Li Y; Vellano CP; Schultz N; Karchin R; Ding L; Lu Y; Cheung LWT; Chen K; Shaw KR; Meric-Bernstam F; Scott KL; Yi S; Sahni N; Liang H; Mills GB
Cancer Cell; 2018 Mar; 33(3):450-462.e10. PubMed ID: 29533785
[TBL] [Abstract][Full Text] [Related]
9. Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Nagashima T; Yamaguchi K; Urakami K; Shimoda Y; Ohnami S; Ohshima K; Tanabe T; Naruoka A; Kamada F; Serizawa M; Hatakeyama K; Matsumura K; Ohnami S; Maruyama K; Mochizuki T; Kusuhara M; Shiomi A; Ohde Y; Terashima M; Uesaka K; Onitsuka T; Nishimura S; Hirashima Y; Hayashi N; Kiyohara Y; Tsubosa Y; Katagiri H; Niwakawa M; Takahashi K; Kashiwagi H; Nakagawa M; Ishida Y; Sugino T; Takahashi M; Akiyama Y
Cancer Sci; 2020 Feb; 111(2):687-699. PubMed ID: 31863614
[TBL] [Abstract][Full Text] [Related]
10. Implementation of "clinical sequencing" in cancer genome medicine in Japan.
Kohno T
Cancer Sci; 2018 Mar; 109(3):507-512. PubMed ID: 29285848
[TBL] [Abstract][Full Text] [Related]
11. Panel Comparative Analysis Tool: An Open-Source Comparative Analysis Tool for Next-Generation Sequencing Panel Target Regions.
Oszwald A; Zisser L; Compérat E; Müllauer L
J Mol Diagn; 2024 May; 26(5):423-429. PubMed ID: 38508412
[TBL] [Abstract][Full Text] [Related]
12. NetNorM: Capturing cancer-relevant information in somatic exome mutation data with gene networks for cancer stratification and prognosis.
Le Morvan M; Zinovyev A; Vert JP
PLoS Comput Biol; 2017 Jun; 13(6):e1005573. PubMed ID: 28650955
[TBL] [Abstract][Full Text] [Related]
13. Personalized cancer care.
Doyle-Lindrud S
J Am Assoc Nurse Pract; 2022 Nov; 34(11):1184-1186. PubMed ID: 36367238
[TBL] [Abstract][Full Text] [Related]
14. Determining Performance Metrics for Targeted Next-Generation Sequencing Panels Using Reference Materials.
Cleveland MH; Zook JM; Salit M; Vallone PM
J Mol Diagn; 2018 Sep; 20(5):583-590. PubMed ID: 29959024
[TBL] [Abstract][Full Text] [Related]
15. Pan-Cancer Molecular Biomarkers: A Paradigm Shift in Diagnostic Pathology.
Dong F
Clin Lab Med; 2024 Jun; 44(2):325-337. PubMed ID: 38821647
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing in precision oncology: Patient understanding and expectations.
Roberts JS; Gornick MC; Le LQ; Bartnik NJ; Zikmund-Fisher BJ; Chinnaiyan AM;
Cancer Med; 2019 Jan; 8(1):227-237. PubMed ID: 30600607
[TBL] [Abstract][Full Text] [Related]
17. REPURPOSING GERMLINE EXOMES OF THE CANCER GENOME ATLAS DEMANDS A CAUTIOUS APPROACH AND SAMPLE-SPECIFIC VARIANT FILTERING.
Koire A; Katsonis P; Lichtarge O
Pac Symp Biocomput; 2016; 21():207-18. PubMed ID: 26776187
[TBL] [Abstract][Full Text] [Related]
18. My personal mutanome: a computational genomic medicine platform for searching network perturbing alleles linking genotype to phenotype.
Zhou Y; Zhao J; Fang J; Martin W; Li L; Nussinov R; Chan TA; Eng C; Cheng F
Genome Biol; 2021 Jan; 22(1):53. PubMed ID: 33514395
[TBL] [Abstract][Full Text] [Related]
19. Cancer evolution: the final frontier of precision medicine?
Swanton C
Ann Oncol; 2014 Mar; 25(3):549-551. PubMed ID: 24567514
[TBL] [Abstract][Full Text] [Related]
20. TMBcalc: a computational pipeline for identifying pan-cancer Tumor Mutational Burden gene signatures.
Privitera GF; Alaimo S; Caruso A; Ferro A; Forte S; Pulvirenti A
Front Genet; 2024; 15():1285305. PubMed ID: 38645485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
